Platelet-activating factor enhances urokinase-type plasminogen activator gene expression in corneal epithelium

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 10, 1996, Pages 2037-2046

  Tao, Ying ^a   Bazan, Haydee E P ^a,b   Bazan, Nicolas G ^a  

^a LSU EYE CENTER   (United States)

^b Louisiana Stale Univ Medical Center   (United States)

Author keywords

corneal epithelium; extracellular matrix; platelet activating factor (PAF); signal transduction; urokinase type plasminogen activator (uPA)

Indexed keywords

6 (2 CHLOROPHENYL) 4,7,8,10 TETRAHYDRO 9 (4 METHOXYPHENYLCARBAMOYL) 1 METHYLPYRIDO[4',3':4,5]THIENO[3,2 F][1,2,4]TRIAZOLO[4,3 A][1,4]DIAZEPINE; [2 METHOXY 3 (N OCTADECYLCARBAMOYLOXY)PROPYL] (2 THIAZOLIOETHYL) PHOSPHATE; ALPHA AMANITIN; APAFANT; BN 50727; CYCLIC AMP; CYCLOHEXIMIDE; DACTINOMYCIN; GINKGOLIDE B; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATE DERIVATIVE; MESSENGER RNA; OKADAIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNCLASSIFIED DRUG; UROKINASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA EPITHELIUM; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; RABBIT;

AMANITINS; ANIMALS; AZEPINES; BLOTTING, NORTHERN; CORNEA; CYCLIC AMP; DACTINOMYCIN; EPITHELIUM; ETHERS, CYCLIC; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GTP-BINDING PROTEINS; OKADAIC ACID; ORGAN CULTURE TECHNIQUES; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION INHIBITORS; PROTEIN SYNTHESIS INHIBITORS; RABBITS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRIAZOLES; URINARY PLASMINOGEN ACTIVATOR;

EID: 0029767458     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Alexander C, Werb Z. Extracellular matrix degradation. In: Hay ED, ed. Cell Biology of Extracellular Matrix. 2nd ed. New York: Plenum Press; 1991:225-301.
2. Moscatelli D, Rifkin DB. Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. Biochim Biophys Acta. 1988;948:67-85.
3. Saksela O, Rifkin DB. Cell associated plasminogen activation: Regulation and physiological functions. Ann Rev Cell Biol. 1988;4:93-126.
4. Vassalli J-D, Sappino A-P, Belin D. The plasminogen activator/plasmin system. J Clin Invest. 1991;88:1067-1072.
5. Berman MB. Regulation of corneal fibroblast MMP-1 collagenase secretion by plasmin. Cornea. 1993; 12:420-432.
6. Blasi F, Vassalli J-D, Dano K. Urokinase-type plasminogen activator: Proenzyme, receptor, and inhibitors. J Cell Biol. 1987;104:801-804.
7. Pandolfi M, Astrup T. A histochemical study of the nbrinolytic activity. Arch Ophthalmol. 1967;77:258-264.
8. Morimoto K, Mishina H, Nishida T, Otori T. Role of urokinase type plasminogen activator (u-PA) in corneal epithelial migration. Thromb Haematost. 1993; 69:387-391.
9. Berman M, Leary R, Gage J. Evidence for a role of the plasminogen activator-plasmin system in corneal ulceration. Invest Ophthalmol Vis Sci. 1980;19:1204-1221.
10. Berman M. The pathogenesis of corneal epithelial defects. Acta Ophthalmol. 1989;192:88-94.
11. Belin D, Vassalli J-D, Combepine C, et al. Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator. Eur J Biochem. 1985;148:225-232.
12. North P, Nerlov C, Blasi F, Johnsen M. Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester. Nucl Acids Res. 1991;18:5009-5017.
13. Lee JS, Favre B, Jemmings BA, Kiefer B, Nagamine Y. Okadaic acid-dependent induction of the urokinase-type plasminogen activator gene associated with stabilization and autoregulation of c-jun. J Biol Chem. 1994;269:2887-2894.
14. Bazan HEP, Reddy STK, Lin N. Platelet-activating factor (PAF) accumulation correlates with injury in the cornea. Exp Eye Res. 1991;52:481-491.
15. Bazan HEP, Tao Y, Bazan NG. Platelet-activating factor induces collagenase expression in corneal epithelial cells. Proc Natl Acad Sci USA. 1993;90:8678-8682.
16. Tao Y, Bazan HEP, Bazan NG. Platelet-activating factor induces the expression of metalloproteinases-1 and -9 but not -2 or -3 in the corneal epithelium. Invest Ophthalmol Vis Sci. 1995;36:345-354.
17. Borle AB, Snowdowne KW. Measurement of intracellular free calcium in monkey kidney cells with aequorin. Science. 1982;217:252-254.
18. Burch RM, Axelrod J. Dissociation of bradykinin-induced prostaglandin formation from phosphatidylinositol turnover in Swiss 3T3 fibroblasts: Evidence for G protein regulation of phospholipase A2. Proc Natl Acad Sci USA. 1987;84:6374-6378.
19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem. 1987;162:156-159.
20. Roche PC, Campeau JD, Shaw ST Jr. Comparative electrophoretic analysis of human and porcine plasminogen activators in SDS-polyacrylamide gels containing plasminogen and casein. Biochim Biophys Acta. 1983;745:82-89.
21. Marcheselli VL, Rossowska M, Domingo MT, Braquet P, Bazan NG. Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex. J Biol Chem. 1990; 265:9140-9145.
22. Bazan NG, Squinto SP, Braquet P, Panetta T, Marcheselli VL. Platelet-activating factor and polyunsaturated fatty acids in cerebral ischemia or convulsions: Intracellular PAF-binding sites and activation of a Fos/Jun/ Ap-1 transcriptional signaling system. Lipids. 1991; 26:1236-1242.
23. Honda Z, Nakamura M, Miki I, et al. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature. 1991;394:342-346.
24. 2 activation probably through uncoupling of a GTP-binding protein from the enzyme in rat peritoneal mast cells. Biochem Pharmacol. 1992;44:45-50.
25. c) regulating receptor-mediated phosphoinositide signalling in human pituitary clonal cells. FEBS Lett. 1987;220:327-331.
26. Kravchenko FF, Pan Z, Han J, Herbert J-M, Ulevitch RJ, Ye RD. Platelet-activating factor induces NF-KB activation through a G protein coupled pathway. J Biol Chem. 1995;270:14928-14934.
27. Collart MA, Belin D, Vassalli J-D, de Kossodo S, Vassalli P. Gamma-interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin-1 and urokinases genes, which are controlled by short-lived repressors. J Exp Med. 1986; 164:2113-2118.
28. Degen JL, Estensen RD, Nagamine Y, Reich E. Induction and desensitization of plasminogen activator gene expression by tumor promoters. J Biol Chem. 1985;260:12426-12433.
29. Bialojan C, Takai A. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Biochem J. 1988;256:283-290.
30. Hayashi K, Herman M, Smith D, El-ghatit A, Pease S, Kenyon KR. Pathogenesis of corneal epithelial defects: Role of plasminogen activator. Curr Eye Res. 1991;10: 381-398.
31. Nakamura M, Honda Z, Izumi T, et al. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J Biol Chem. 1991;266:20400-20405.
32. Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR. Phosphorylation of c-jun mediated by MAP kinases. Nature. 1991;353:670-674.
33. Varner L, Bazan HEP. A mitogen-activated protein kinase (MAP-K) cascade is stimulated by platelet-activating factor (PAF) in cornea epithelium. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1995;36:S141.
34. Lee JS, Catanzariti L, Hemmings BA, Kiefer B, Nagamine Y. Activation of cAMP-dependent protein kinase alters the chromatin structure of the urokinase-type plasminogen activator gene promoter. Nucl Acids Res. 1994;22:569-575.
35. Snyder F. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol. 1990;259:C697-C708.
36. Prescott SM, Zimmerman GA, McIntyre TM. Platelet-activating factor. J Biol Chem. 1990;265:17381-17384.
37. Hilliquin P, Menkes CJ, Laoussadi S, Benveniste J, Arnoux B. Presence of PAF-acether in rheumatic diseases. Ann Rheum Dis. 1992;51:29-31.
38. Saxne T, Lacander P, Geborel P. Plasminogen activators and plasminogen activator inhibitors in synovial fluid: Difference between inflammatory joint disorders and osteoarthritis. J Rheumatol. 1993;20:91-96.
39. Kramer MD, Hansch GM, Rother KO. Complements and plasminogen: Pathways in inflammation. Behring Inst Mitt. 1992;91:145-156.